The Organs in Acute-on-Chronic Liver Failure

Abstract

In this review to the authors provide evidence-based definitions of organ failure in patients with acute decompensation of cirrhosis, describe the prevalence and prognostic impact of organ failure in these patients, and highlight current knowledge of the mechanisms responsible for its development. Excessive inflammatory response and a reduction of the capacity of organs to respond adequately to stress may sensitize cirrhotic patients to inflammation-driven organ damage and failure. The dynamic evolution of organ failure during early intensive management may provide a useful tool for guiding subsequent management strategies, or in some cases, for defining the futility of care. Currently, management of patients with acute-on-chronic liver failure is mainly supportive. Understanding the mechanisms of immunopathology and failed organ tolerance in acute decompensated cirrhosis could open new areas of research and define new therapeutic options in this life-threatening condition.

Keywords

organ failure - cirrhosis - immunopathology - intensive care

• References

• 1 Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr Opin Crit Care 2011; 17 (2) 165-169
• 2 Jalan R, Stadlbauer V, Sen S, Cheshire L, Chang YM, Mookerjee RP. Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study. Crit Care 2012; 16 (6) R227
• 3 Levesque E, Hoti E, Azoulay D , et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2012; 56 (1) 95-102
• 4 Moreau R, Jalan R, Gines P , et al; CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144 (7) 1426-1437 , 1437.e1–1437.e9
• 5 Gustot T, Fernandez J, Garcia E , et al; CANONIC Study Investigators of the EASL-CLIF Consortium. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology 2015; 62 (1) 243-252
• 6 Shi Y, Yang Y, Hu Y , et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology 2015; 62 (1) 232-242
• 7 Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011; 17 (2) 153-159
• 8 Navasa M, Follo A, Filella X , et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998; 27 (5) 1227-1232
• 9 Fernández J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol 2012; 56 (Suppl. 01) S1-S12
• 10 Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 2012; 335 (6071) 936-941
• 11 Jamieson AM, Pasman L, Yu S , et al. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 2013; 340 (6137) 1230-1234
• 12 Jalan R, Saliba F, Pavesi M , et al; CANONIC study investigators of the EASL-CLIF Consortium. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014; 61 (5) 1038-1047
• 13 Adebayo D, Morabito V, Andreola F , et al. Mechanism of cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study. Liver Int 2015; 35 (12) 2564-2574
• 14 Li H, Xia Q, Zeng B , et al. Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation. J Hepatol 2015; 63 (1) 50-59
• 15 Tazi KA, Bièche I, Paradis V , et al. In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats. J Hepatol 2007; 46 (6) 1075-1088
• 16 Ren F, Shi H, Zhang L , et al. The dysregulation of endoplasmic reticulum stress response in acute-on-chronic liver failure patients caused by acute exacerbation of chronic hepatitis. B. J Viral Hep 2016; 23 (1) 23-31
• 17 Trinchet JC, Gerhardt MF, Balkau B, Munz C, Poupon RE. Serum bile acids and cholestasis in alcoholic hepatitis. Relationship with usual liver tests and histological features. J Hepatol 1994; 21 (2) 235-240
• 18 Chand N, Sanyal AJ. Sepsis-induced cholestasis. Hepatology 2007; 45 (1) 230-241
• 19 Katoonizadeh A, Laleman W, Verslype C , et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 2010; 59 (11) 1561-1569
• 20 Altamirano J, Miquel R, Katoonizadeh A , et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 2014; 146 (5) 1231-9.e1 , 6
• 21 Dubuquoy L, Louvet A, Lassailly G , et al. Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis. Gut 2015; 64 (12) 1949-1960
• 22 Williams MJ, Clouston AD, Forbes SJ. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology 2014; 146 (2) 349-356
• 23 Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006; 43 (1) 2-8
• 24 Yannaki E, Athanasiou E, Xagorari A , et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 2005; 33 (1) 108-119
• 25 Spahr L, Lambert JF, Rubbia-Brandt L , et al. Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial. Hepatology 2008; 48 (1) 221-229
• 26 Garg V, Garg H, Khan A , et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology 2012; 142 (3) 505-512.e1
• 27 García-Pagán JC, Gracia-Sancho J, Bosch J. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol 2012; 57 (2) 458-461
• 28 Mookerjee RP. Acute-on-chronic liver failure: the liver and portal haemodynamics. Curr Opin Crit Care 2011; 17 (2) 170-176
• 29 Mookerjee RP, Wiesenthal A, Icking A , et al. Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis. Gastroenterology 2007; 132 (7) 2533-2541
• 30 Shah V, Cao S, Hendrickson H, Yao J, Katusic ZS. Regulation of hepatic eNOS by caveolin and calmodulin after bile duct ligation in rats. Am J Physiol Gastrointest Liver Physiol 2001; 280 (6) G1209-G1216
• 31 Mookerjee RP, Dalton RN, Davies NA , et al. Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure. Liver Transpl 2007; 13 (3) 400-405
• 32 Mehta G, Mookerjee RP, Sharma V, Jalan R. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure. Liver Int 2015; 35 (3) 724-734
• 33 Mookerjee RP, Sen S, Davies NA, Hodges SJ, Williams R, Jalan R. Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut 2003; 52 (8) 1182-1187
• 34 Albillos A, de la Hera A, González M , et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37 (1) 208-217
• 35 Rasaratnam B, Kaye D, Jennings G, Dudley F, Chin-Dusting J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 2003; 139 (3) 186-193
• 36 Bátkai S, Járai Z, Wagner JA , et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001; 7 (7) 827-832
• 37 Rautou PE, Bresson J, Sainte-Marie Y , et al. Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis. Gastroenterology 2012; 143 (1) 166-76.e6
• 38 Gustot T, Felleiter P, Pickkers P , et al; EPIC II Group of Investigators. Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study. Liver Int 2014; 34 (10) 1496-1503
• 39 Ruiz-del-Arbol L, Urman J, Fernández J , et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003; 38 (5) 1210-1218
• 40 Ruiz-del-Arbol L, Monescillo A, Arocena C , et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005; 42 (2) 439-447
• 41 Liu H, Lee SS. Nuclear factor-kappaB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy. Liver Int 2008; 28 (5) 640-648
• 42 Galbois A, Bigé N, Pichereau C , et al. Exploration of skin perfusion in cirrhotic patients with septic shock. J Hepatol 2015; 62 (3) 549-555
• 43 Thomson SJ, Cowan ML, Forton DM , et al. A study of muscle tissue oxygenation and peripheral microcirculatory dysfunction in cirrhosis using near infrared spectroscopy. Liver Int 2010; 30 (3) 463-471
• 44 Caraceni P, Dazzani F, Salizzoni E , et al. Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. J Hepatol 2008; 48 (4) 559-566
• 45 Acevedo J, Fernández J, Prado V , et al. Relative adrenal insufficiency in decompensated cirrhosis: Relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death. Hepatology 2013; 58 (5) 1757-1765
• 46 Cárdenas A, Ginès P. Acute-on-chronic liver failure: the kidneys. Curr Opin Crit Care 2011; 17 (2) 184-189
• 47 Fernández J, Escorsell A, Zabalza M , et al. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology 2006; 44 (5) 1288-1295
• 48 Arabi YM, Aljumah A, Dabbagh O , et al. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ 2010; 182 (18) 1971-1977
• 49 Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int 2003; 23 (2) 71-77
• 50 Wong F, Nadim MK, Kellum JA , et al. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 2011; 60 (5) 702-709
• 51 Wong F, O'Leary JG, Reddy KR , et al; North American Consortium for Study of End-Stage Liver Disease. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology 2013; 145 (6) 1280-1288.e1
• 52 Martín-Llahí M, Guevara M, Torre A , et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011; 140 (2) 488-496.e4
• 53 Ariza X, Solà E, Elia C , et al. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis. PLoS ONE 2015; 10 (6) e0128145
• 54 Trawalé JM, Paradis V, Rautou PE , et al. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int 2010; 30 (5) 725-732
• 55 Shah N, Mohamed FE, Jover-Cobos M , et al. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver Int 2013; 33 (3) 398-409
• 56 Shah N, Dhar D, El Zahraa Mohammed F , et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. J Hepatol 2012; 56 (5) 1047-1053
• 57 Cordoba J, Ventura-Cots M, Simón-Talero M , et al; CANONIC Study Investigators of EASL-CLIF Consortium. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 2014; 60 (2) 275-281
• 58 Romero-Gómez M, Jover M, Del Campo JA , et al. Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study. Ann Intern Med 2010; 153 (5) 281-288
• 59 Laleman W, Simon-Talero M, Maleux G , et al; EASL-CLIF-Consortium. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology 2013; 57 (6) 2448-2457
• 60 Shawcross DL, Sharifi Y, Canavan JB , et al. Infection and systemic inflammation, not ammonia, are associated with grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol 2011; 54 (4) 640-649
• 61 Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004; 40 (2) 247-254
• 62 Rodrigo R, Cauli O, Gomez-Pinedo U , et al. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 2010; 139 (2) 675-684
• 63 Joshi D, O'Grady J, Patel A , et al. Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with high-grade hepatic encephalopathy. Liver Int 2014; 34 (3) 362-366
• 64 Cárdenas A, Solà E, Rodríguez E , et al; CANONIC study investigators of the EASL-CLIF Consortium. Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study. Crit Care 2014; 18 (6) 700
• 65 Tripodi A, Primignani M, Chantarangkul V , et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009; 137 (6) 2105-2111
• 66 Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest 1966; 45 (5) 645-657
• 67 Cahill PA, Redmond EM, Sitzmann JV. Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 2001; 89 (3) 273-293
• 68 Lisman T, Bongers TN, Adelmeijer J , et al. Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006; 44 (1) 53-61
• 69 Caldwell SH, Hoffman M, Lisman T , et al; Coagulation in Liver Disease Group. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006; 44 (4) 1039-1046
• 70 Francoz C, Belghiti J, Vilgrain V , et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54 (5) 691-697
• 71 Tripodi A. Hemostasis abnormalities in cirrhosis. Curr Opin Hematol 2015; 22 (5) 406-412
• 72 Wallaert B, Aerts C, Colombel JF, Voisin C. Human alveolar macrophage antibacterial activity in the alcoholic lung. Am Rev Respir Dis 1991; 144 (2) 278-283
• 73 Wallaert B, Colombel JF, Prin L, Sibille Y, Tonnel AB. Bronchoalveolar lavage in alcoholic liver cirrhosis. T-lymphocyte subsets and immunoglobulin concentrations. Chest 1992; 101 (2) 468-473
• 74 Matuschak GM, Rinaldo J, Pinsky MR, Gavaler JS, Van Thiel DH. Effect of end-stage liver failure on the incidence and resolution of the adult respiratory distress syndrome. J Crit Care 1987; 2 (3) 162-173
• 75 Chang SW, Ohara N. Chronic biliary obstruction induces pulmonary intravascular phagocytosis and endotoxin sensitivity in rats. J Clin Invest 1994; 94 (5) 2009-2019
• 76 Matuschak GM. Lung-liver interactions in sepsis and multiple organ failure syndrome. Clin Chest Med 1996; 17 (1) 83-98
• 77 Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995; 152 (6 Pt 1) 1818-1824
• 78 Rabe C, Schmitz V, Paashaus M , et al. Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation. Intensive Care Med 2004; 30 (8) 1564-1571
• 79 Levesque E, Saliba F, Ichaï P, Samuel D. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol 2014; 60 (3) 570-578